Profil
Mac Taketani currently works at CarbGeM Inc., as Chief Business Officer.
Postes actifs de Mac Taketani
| Sociétés | Poste | Début |
|---|---|---|
CarbGeM Inc.
 CarbGeM Inc. Miscellaneous Commercial ServicesCommercial Services CarbGeM Inc. is a Japanese company that aims to protect humanity from the threat of bacterial infections and realize a safer world. The company is based in Shibuya-ku, Japan. The company focuses on solving infectious diseases and drug resistance issues through next-generation AI medical innovation using AI image analysis technology. The company aims to build seeds and product development platforms in the life science field through research and development of next-generation technology related to the infectious disease field. The company has developed a point of care automatic gram dye called "Bitte" that can provide doctors and laboratory technicians with estimates of bacterial infections and help them select appropriate antibiotics. The company was founded in 2016 by Masakazu Nakajima, who has been the CEO since then. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
CarbGeM Inc.
CarbGeM Inc. Miscellaneous Commercial ServicesCommercial Services CarbGeM Inc. is a Japanese company that aims to protect humanity from the threat of bacterial infections and realize a safer world. The company is based in Shibuya-ku, Japan. The company focuses on solving infectious diseases and drug resistance issues through next-generation AI medical innovation using AI image analysis technology. The company aims to build seeds and product development platforms in the life science field through research and development of next-generation technology related to the infectious disease field. The company has developed a point of care automatic gram dye called "Bitte" that can provide doctors and laboratory technicians with estimates of bacterial infections and help them select appropriate antibiotics. The company was founded in 2016 by Masakazu Nakajima, who has been the CEO since then. | Commercial Services |
